dc.contributorDiaz Manrique, Diana Paola
dc.creatorDiaz Manrique, Diana Paola
dc.creatorCarrillo Rodriguez, Adriana Patricia
dc.date.accessioned2015-06-09T18:32:23Z
dc.date.available2015-06-09T18:32:23Z
dc.date.created2015-06-09T18:32:23Z
dc.date.issued2015
dc.identifierhttp://repository.urosario.edu.co/handle/10336/10511
dc.identifierhttps://doi.org/10.48713/10336_10511
dc.description.abstractIntroduction: Breast cáncer is the leading cause of cáncer among women and the first cause of cáncer related death among Hispanic and second cause among other races, not taking into account the great social and economic impact, associated with this pathology. This encourages the realization of own studies that expand our knowledge and contribute to the Colombian literature, a publication that reflects the factors associated with breast cáncer recurrence. Methods: A retrospective analytical observational case-control study. 267 medical records of patients diagnosed with breast cáncer were taken, classified according to clinical stage and molecular expression of the tumor; the factors strongly associated to recurrence were analyzed. Results: The total population consisted of 267 women of which 58 presented recurrence, with a case – control ratio 1:3,6. At the time of evaluation of the groups, age, tumor classification, parity and histology, it was concluded that these groups are comparable. A mortality rate of 13.8% in patients who had tumor recurrence vs 0% mortality in those cases with no recurrence was observed. Additionally, a relationship between the presence of HER 2 receptor and tumor relapse is evident, although it is not statistically significant, it is important to consider its clinical implication. The presence of estrogen and progesterone receptor is not a predictor of recurrence. Performing surgery has shown to be a protective factor. Finally, age, clinical stage at the time of diagnosis and molecular tumor classification shown statistically significant association to breast cáncer recurrence. Conclusions: Factors associated with recurrence in patients with breast cáncer in an institution of Bogotá, Colombia are: age, clinical stage at diagnosis and molecular classification of tumor. This findings confirm the aggressiveness of triple negative tumors. All findings are compatible with the ones described in the literature, but our study was aimed to a specific population, with specific characteristics.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherFacultad de medicina
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto completo)
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.source1. Badar, F., Moid, I., Waheed, F., Zaidi, A., Naqvi, B., & Yunus, S. (2005). Variables associated with recurrence in breast cancer patients-the Shaukat Khanum Memorial experience. Asian Pacific journal of cancer prevention, 6-54.
dc.source. Cancerologia, I. N. (2005). Incidencia Estimada y Mortalidad por Cancer en Colombia. Instituto Nacional de Cancerologia.
dc.source3. CK, K. (008 de 2005). Mammography, breast ultrasound, and magnetic resonance imagining for surveillance of womwn at high familial risk for breast cancer. J Clin Oncolo, 23, 8469 - 76.
dc.source4. DR, Y. (027 de 03 de 2012). The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality. Cencer Epidemiology, 36, 237 - 48.
dc.source5.Fatma P Turkoz. (s.f.). Association between common risk factors and molecular subtypes in breast-cancer-patients.
dc.source6. Heitz F1. (011 de 2009). Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. European Journal of Cancer, 45(16), 2792-8.
dc.source7. J I. Arraras Urdaniz. (2003). The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality. Rev Cli Esp, 203(12), 577 - 81.
dc.source8. J, W. (012 de 2008). What is triple - negative brast cancer? The Journal of Cancer, 44(18), 2799 - 2805.
dc.source9. Lord, S. (009 de 2007). A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. 43(13), 1905 - 17.
dc.source10. Mann, R. (007 de 2008). Breast MRI: guidelines from de European Society of Breast Imaging. . Eur Radiol, 18(7), 1307 - 18.
dc.source11. Mininsterio de Protección Social - Departamento Administrativo de Ciencia Tecnología e Innovación en Salud. (2013). Guía de Práctica Clínica para la Detección Temprana, Tratamiento Integral, Seguimiento y Rehabilitación de Pacientes con Cancer de Mama. Sistema de Seguridad Social(19).
dc.source12. National Comprehensive Cancer Network. (2011). Obtenido de www.nccn.org
dc.source13. PA, C. (2003). Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med, 138, 168 - 75.
dc.source14. Prevention, C. f. (2008). Obtenido de www.cdc.gov
dc.source15. Rudra, S., Yu, D. S., Yu, E. S., & al, e. (2015). Locoregional and Distant Recurrence Patterns in Young versus. International Journal of Breast Cancer, 1-10.
dc.source16. Sabine C. (009 de 2009). Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept support. European Journal of Cancer, 45, 11 - 26.
dc.source17. Social, M. d. (2009). Estudios sobre la Calidad de Vida de Pacientes Afectados por Determinadas Patologías. . Madrid.
dc.source18. Therese Sørlie. (005 de 2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci , 100(14).
dc.source19. Vila, M. M. (010 de 2009). Supervivencia tras la primera recidiva en cáncer de mama, ¿se puede individualizar? 133(13).
dc.source20. WA, B. (Mayo de 2008). Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer . JAMA, 299(18), 2151-63.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectCáncer de seno
dc.subjectTriple negativo
dc.subjectReceptores de estrógenos positivos y negativos
dc.subjectReceptores de progesterona positivos y negativos
dc.subjectLuminal A
dc.subjectLuminal B
dc.subjectSobreexpresión de HER 2
dc.subjectGanglios positivos
dc.titleFactores asociados a recaída en pacientes con cáncer de mama de una institución de Bogotá
dc.typebachelorThesis


Este ítem pertenece a la siguiente institución